
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 2.980 | 55.850 | 52.870 |
Shares | 96.190 | 96.340 | 0.150 |
Bonds | 0.130 | 0.140 | 0.010 |
Other | 0.690 | 0.730 | 0.040 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 17.391 | 20.266 |
Price to Book | 3.206 | 4.014 |
Price to Sales | 1.443 | 2.430 |
Price to Cash Flow | 12.812 | 16.187 |
Dividend Yield | 2.532 | 1.376 |
5 Years Earnings Growth | 9.285 | 11.911 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 45.850 | 94.848 |
Financial Services | 23.740 | 8.655 |
Consumer Cyclical | 18.210 | 8.267 |
Industrials | 4.420 | 2.516 |
Real Estate | 3.790 | 1.841 |
Technology | 2.590 | 2.806 |
Consumer Defensive | 1.400 | 3.305 |
Number of long holdings: 142
Number of short holdings: 90
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Allianz | DE0008404005 | 3.16 | 348.20 | +0.26% | |
Novo Nordisk B | DK0062498333 | 3.15 | 421.3 | -1.03% | |
MetLife | US59156R1086 | 3.00 | 72.55 | +1.19% | |
Sun Life Financial | CA8667961053 | 2.78 | 78.11 | -0.31% | |
BlackRock | US09290D1019 | 2.69 | 875.78 | +1.16% | |
Eli Lilly | US5324571083 | 2.62 | 839.96 | +14.30% | |
SCI | US8175651046 | 2.56 | 77.59 | +1.23% | |
Boston Scientific | US1011371077 | 2.53 | 95.12 | -0.14% | |
Apple | US0378331005 | 2.49 | 196.98 | +1.39% | |
Legal & General | GB0005603997 | 2.41 | 247.60 | +0.53% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
LU1530899142 | 2.79B | -14.89 | -0.06 | - | ||
LU2035461495 | 2.79B | -14.78 | 0.21 | - | ||
LU1903290036 | 2.79B | -13.06 | -1.24 | - | ||
LU1530900684 | 2.79B | -14.70 | 0.94 | - | ||
LU1902444402 | 1.6B | -5.65 | 4.87 | - |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review